Therapath LLC (www.Therapath.com),a leader in neuropathology laboratory services, has established normative values for two upper limb body sites that can...

Synergy Pharmaceuticals Inc., today announced its Chairman and Chief Executive Officer, Dr. Gary S. Jacob, will present a corporate update...

Cardiome Pharma Corp. today announced that it will report financial results for the second quarter ended June 30, 2014 on...

Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced...

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended June 30, 2014. For the second...

Total Revenue of $68.2 million, including Contract Revenue of $61.5 Million, up 15%   Adjusted Diluted EPS of $0.22, up...